STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may help tailor lung cancer therapy
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab improves survival in people with advanced non-small cell lung cancer. About 63 participants with high PD-L1 levels will receive cemiplimab first, and …
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy aims to boost lung cancer treatment success
Disease control Recruiting nowThis study tests a new way to give radiation therapy (using PET scans to target smaller areas) along with standard chemo and an immunotherapy drug (durvalumab) for people with stage III lung cancer that cannot be removed by surgery. About 110 adults will be randomly assigned to e…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated May 11, 2026 20:40 UTC